Price $5.30 |
Market Cap
164.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
61.6K
|
FCF
-
|
|
Op. Margin
-526.10%
|
Net Margin
-
|
ROE
-
|
ROI
-
|
|
ROA
-
|
EPS Growth
8.50%
|
Current Ratio
6.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pressure Biosciences Inc (PBIO) | $0.26 | - | - | 8.4M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.70 | - | - | 183.6M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $1.02 | - | - | 1.2M | Strong Buy |
| ATI Physical Therapy Inc (ATIP) | $4.03 | - | - | 30.8M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
